Mystery designation of Rare Diseases
The prevalence of rare diseases is between 2 and 4%. Children between the ages of 3 and 5 are most at risk. Eighty percent of uncommon illnesses are genetic in character, therefore ordination sequencing-based designation offers an encouraging alternative for the management of rare diseases. Mystery designation for rare diseases is entire ordination sequencing. By analysing many genes, ordination sequencing, which has a diagnosis rate of 62.5%, will be utilised to analyse rare and unknown illnesses in order to identify the relevant.
Related Conference of Mystery designation of Rare Diseases
May 14-15, 2026
13th International Conference on Infectious Diseases, Bacteriology and Antibiotics
Paris, France
May 18-19, 2026
6th World Congress on Tuberculosis, Lung Infections, and Respiratory Care
Paris, France
June 02-03, 2026
7th International Conference on Microbiology and Infectious Diseases
Toronto, Canada
July 20-21, 2026
10th International Conference on Infectious Diseases: Control and Prevention
London, UK
August 25-26, 2026
18th Global Conference on Nephrology and Infectious Diseases
Amsterdam, Netherlands
October 05-06, 2026
14th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs
Madrid, Spain
Mystery designation of Rare Diseases Conference Speakers
Recommended Sessions
- Clinical analysis and Treatment
- Infectious Diseases
- Mystery designation of Rare Diseases
- Neglected Tropical Diseases
- Orphan medicine
- Rare Cancer Diseases
- Rare Diseases
- Rare Diseases analysis
- Rare Diseases in Brain
- Rare Endocrine Genetic Diseases
- Rare Genetic Diseases
- Rare hematology Diseases
- Rare paediatrics Diseases
- Rare response Diseases
- Rare Skin Diseases
- Treatment for Rare Diseases
Related Journals
Are you interested in
- Advances in Chronic Kidney Disease (CKD) Management - GLOBAL INFECTIONS 2026 (Netherlands)
- Advances in Pulmonary Care and Rehabilitation - Tuberculosis 2026 (France)
- Advances in Tuberculosis Diagnosis - Tuberculosis 2026 (France)
- Alcohol and Drug Use - STD-HIV AIDS-2026 (Spain)
- Antimicrobial Resistance (AMR) - Infection Congress 2026 (UK)
- Antimicrobial Stewardship in Respiratory Care - Tuberculosis 2026 (France)
- Antimicrobial Stewardship/Antimicrobial Resistance - Infection Prevention 2026 (Spain)
- Artificial Intelligence and Machine Learning in Nephrology - GLOBAL INFECTIONS 2026 (Netherlands)
- Bacterial & Fungal Infectious Diseases - Infectious Diseases_2026 (France)
- Bacterial Infections and Antimicrobial Resistance (AMR) - Euro Infectious Diseases 2026 (UK)
- Bacterial Infectious Diseases - INFECTIOUS DISEASES-2026 (France)
- Bacterial, Parasitic and Fungal Infections - Infection Prevention 2026 (Spain)
- Biomarkers for Rare Disease Diagnosis and Treatment - Rare Diseases Congress 2026 (Czech Republic)
- Biomedical Research - Rare Diseases Congress 2026 (Czech Republic)
- Blood Borne Infections/Sepsis/Septicaemia - Infection Prevention 2026 (Spain)
- Cardio-Renal Syndromes - GLOBAL INFECTIONS 2026 (Netherlands)
- Causes and Symptoms of Infections - Infection Prevention 2026 (Spain)
- Causes and Symptoms of Infectious Diseases - INFECTIOUS DISEASES-2026 (France)
- Challenges of Living with a Rare Disease: - Rare Diseases Congress 2026 (Czech Republic)
- Climate Change and Infectious Diseases - Infection Congress 2026 (UK)
- Climate Change, Urbanization, and Infectious Disease Spread - Euro Infectious Diseases 2026 (UK)
- Clinical and Case Reports - INFECTIOUS DISEASES-2026 (France)
- Clinical Case Reports and Case Studies - Rare Diseases Congress 2026 (Czech Republic)
- Clinical Management of Infectious Diseases - INFECTIOUS DISEASES-2026 (France)
- Clinical Research and Case Reports - STD-HIV AIDS-2026 (Spain)
- Clinical Research and Public Awareness - Infectious Diseases_2026 (France)
- Clinical Research on Orphan Drugs - Rare Diseases Congress 2026 (Czech Republic)
- Co-infections Associated with STD - STD-HIV AIDS-2026 (Spain)
- Coronavirus Disease (COVID-19) - INFECTIOUS DISEASES-2026 (France)
- Coronavirus(nCOV) - Infectious Diseases_2026 (France)
- COVID-19 Variants - Infection Congress 2026 (UK)
- Covid_19 Infections - Infection Prevention 2026 (Spain)
- Diagnosis and Treatment - STD-HIV AIDS-2026 (Spain)
- Diagnosis f infectious Diseases - Infection Prevention 2026 (Spain)
- Diagnosis, Management and Treatment of Infections - GLOBAL INFECTIONS 2026 (Netherlands)
- Diagnostics and Molecular Tools in Infectious Disease - Euro Infectious Diseases 2026 (UK)
- Different Types of Rare Diseases: - Rare Diseases Congress 2026 (Czech Republic)
- Disinfection and Sterilization - Infection Control 2026 (UK)
- Drug Discovery for Rare Diseases: - Rare Diseases Congress 2026 (Czech Republic)
- Drug-Resistant Tuberculosis and Treatment Strategies - Tuberculosis 2026 (France)
- Ebola and Zika Viral Infections - Infectious Diseases_2026 (France)
- Emerging & Infectious Disease - GLOBAL INFECTIONS 2026 (Netherlands)
- Emerging & Infectious Disease - GLOBAL INFECTIONS 2026 (Netherlands)
- Emerging and Re-Emerging Infections - Infection Prevention 2026 (Spain)
- Emerging and Zoonotic Respiratory Infections - Tuberculosis 2026 (France)
- Emerging Infectious Diseases - Infection Control 2026 (UK)
- Emerging Infectious Diseases - Infection Congress 2026 (UK)
- Emerging Technologies in Rare Disease Research - Rare Diseases Congress 2026 (Czech Republic)
- Environmental and Occupational Lung Diseases - Tuberculosis 2026 (France)
- Epidemiology - INFECTIOUS DISEASES-2026 (France)
- Epidemiology - Infection Prevention 2026 (Spain)
- Epidemiology and Public Health - Infection Congress 2026 (UK)
- Fungal Infections: Diagnosis and Emerging Threats - Euro Infectious Diseases 2026 (UK)
- Fungal Infectious Diseases - INFECTIOUS DISEASES-2026 (France)
- Future Directions in Respiratory Medicine - Tuberculosis 2026 (France)
- Gastrointestinal and Urinary Tract Infections - Infection Prevention 2026 (Spain)
- Genetic and Molecular Insights in Nephrology - GLOBAL INFECTIONS 2026 (Netherlands)
- Global Health and Policy Approaches to TB and Respiratory Care - Tuberculosis 2026 (France)
- Global Health Security - Infection Congress 2026 (UK)
- Global Trends in Emerging Infections - Infection Prevention 2026 (Spain)
- Global Trends in Emerging Infectious Diseases - Infectious Diseases_2026 (France)
- Health Disparities in Nephrology and Infectious Diseases - GLOBAL INFECTIONS 2026 (Netherlands)
- Health Economics and Market Access for Orphan Drugs - Rare Diseases Congress 2026 (Czech Republic)
- Hepatitis Prevention - Infection Control 2026 (UK)
- Hepatitis Prevention - Infection Prevention 2026 (Spain)
- HIV and Women's Health Issues - STD-HIV AIDS-2026 (Spain)
- HIV Prevention, Treatment and Cure - Infection Control 2026 (UK)
- HIV/AIDS - Infectious Diseases_2026 (France)
- HIV/AIDS and Sexually Transmitted Infections (STIs) - Euro Infectious Diseases 2026 (UK)
- Hospital-Acquired Infections (Nosocomial Infections) - Infection Congress 2026 (UK)
- Immunizations and Vaccination - Infection Prevention 2026 (Spain)
- Immunology of Infections - Infectious Diseases_2026 (France)
- Immunology of Tuberculosis and Respiratory Infections - Tuberculosis 2026 (France)
- Impact of COVID-19 on Kidney Health: - GLOBAL INFECTIONS 2026 (Netherlands)
- Infection Control and Hospital-Acquired Infections (HAIs) - Euro Infectious Diseases 2026 (UK)
- Infection Control and Hospital-Acquired Respiratory Diseases - Tuberculosis 2026 (France)
- Infection Control Bacteriology - Infection Control 2026 (UK)
- Infection Control Business - Infection Control 2026 (UK)
- Infection Control in Critical Care - Infection Prevention 2026 (Spain)
- Infection Control in Dental - Infection Control 2026 (UK)
- Infection Control in Dental - Infection Control 2026 (UK)
- Infection Control in Nephrology Units - GLOBAL INFECTIONS 2026 (Netherlands)
- Infection Control Precautions - Infection Control 2026 (UK)
- Infection Control Procedures - Infection Prevention 2026 (Spain)
- Infection Control Treatment & Diagnosis - Infection Control 2026 (UK)
- Infection Prevention and Control - Infection Prevention 2026 (Spain)
- Infection Prevention and Control (IPC) - Infection Congress 2026 (UK)
- Infection Treatment and Control - Infection Control 2026 (UK)
- Infection, Immunity and Inflammation - INFECTIOUS DISEASES-2026 (France)
- Infectious Disease Pathology - Infection Control 2026 (UK)
- Infectious Diseases - INFECTIOUS DISEASES-2026 (France)
- Infectious Diseases and Immune Deficiencies - Rare Diseases Congress 2026 (Czech Republic)
- Infectious Diseases and Neuro Infectious Diseases - Infectious Diseases_2026 (France)
- Infectious Diseases Epidemiology - INFECTIOUS DISEASES-2026 (France)
- Infectious Diseases Prevention, Control and Cure - INFECTIOUS DISEASES-2026 (France)
- Infectious Diseases Prevention, Control and Cure - Infectious Diseases_2026 (France)
- Influenza and Diagnostic Approaches - Infection Control 2026 (UK)
- Innovative Drug Delivery Systems for Respiratory Therapy - Tuberculosis 2026 (France)
- Internal Medicine for Infectious Diseases - INFECTIOUS DISEASES-2026 (France)
- Introduction and Causes of New Rare Diseases: - Rare Diseases Congress 2026 (Czech Republic)
- Malaria and Hepatitis - Infectious Diseases_2026 (France)
- Molecular Bacteriology Infection - GLOBAL INFECTIONS 2026 (Netherlands)
- Neuro Infections - Infection Prevention 2026 (Spain)
- Neuro Infectious Diseases - INFECTIOUS DISEASES-2026 (France)
- New Antiviral, Antibacterial and Antifungal Agents - Infectious Diseases_2026 (France)
- Nosocomial Infections - Infectious Diseases_2026 (France)
- Nosocomial Infections & Control - INFECTIOUS DISEASES-2026 (France)
- Nosocomial Infections & Control - Infection Control 2026 (UK)
- Nosocomial Infections and Control - Infection Prevention 2026 (Spain)
- Nursing Infection Control - Infection Control 2026 (UK)
- Nutrition and Lifestyle Interventions in Respiratory Health - Tuberculosis 2026 (France)
- One Health and Emerging Global Threats - Euro Infectious Diseases 2026 (UK)
- One Health Approach - Infection Congress 2026 (UK)
- Ophthalmological Infections - Infection Prevention 2026 (Spain)
- Orphan Drugs Potentiality - Rare Diseases Congress 2026 (Czech Republic)
- Pandemic Preparedness - Infection Congress 2026 (UK)
- Parasitic Diseases - Infectious Diseases_2026 (France)
- Parasitic Infections and Neglected Tropical Diseases (NTDs) - Euro Infectious Diseases 2026 (UK)
- Parasitology & Infectious Diseases - INFECTIOUS DISEASES-2026 (France)
- Pediatric and Neonatal Respiratory Care - Tuberculosis 2026 (France)
- Pediatric HIV - STD-HIV AIDS-2026 (Spain)
- Pediatric Infectious Disease - GLOBAL INFECTIONS 2026 (Netherlands)
- Pediatric Infectious Diseases - INFECTIOUS DISEASES-2026 (France)
- Pediatric Infectious Diseases - Infection Prevention 2026 (Spain)
- Pediatric Infectious Diseases and Immunization Programs - Euro Infectious Diseases 2026 (UK)
- Pediatric Infectious Diseases/ Childhood Infectious Diseases - Infectious Diseases_2026 (France)
- Pediatric Tuberculosis: Diagnosis and Management - Tuberculosis 2026 (France)
- Pharmacology of Infectious Diseases - INFECTIOUS DISEASES-2026 (France)
- Plants Diseases and Infection Control - Infection Prevention 2026 (Spain)
- Practical Guidelines - Infection Control 2026 (UK)
- Practices & Awareness - Infection Control 2026 (UK)
- Public Health - STD-HIV AIDS-2026 (Spain)
- Pulmonary Critical Care and Intensive Management - Tuberculosis 2026 (France)
- Pulmonary Emergencies and Acute Care Management - Tuberculosis 2026 (France)
- Pulmonary Fibrosis and Chronic Lung Diseases - Tuberculosis 2026 (France)
- Pulmonary Hypertension and Vascular Lung Diseases - Tuberculosis 2026 (France)
- Pulmonary Imaging and Radiology - Tuberculosis 2026 (France)
- Pulmonary Oncology and Lung Cancer Management - Tuberculosis 2026 (France)
- Pulmonary Rehabilitation and Post-Infection Recovery - Tuberculosis 2026 (France)
- Rapid Diagnostic Technologies - Infection Congress 2026 (UK)
- Rare Autoimmune Disorders: - Rare Diseases Congress 2026 (Czech Republic)
- Rare Bone Diseases - Rare Diseases Congress 2026 (Czech Republic)
- Rare Cancer - Rare Diseases Congress 2026 (Czech Republic)
- Rare Diseases and Orphan Drugs: - Rare Diseases Congress 2026 (Czech Republic)
- Rare Diseases in Cancer and Aging - Infectious Diseases_2026 (France)
- Rare Infectious Diseases - Infection Prevention 2026 (Spain)
- Rare Infectious Diseases and Immune Deficiencies - Infectious Diseases_2026 (France)
- Rare Nutritional and Metabolic Diseases - Rare Diseases Congress 2026 (Czech Republic)
- Rare Skin Diseases - Rare Diseases Congress 2026 (Czech Republic)
- Recent Advancements - STD-HIV AIDS-2026 (Spain)
- Renal Replacement Therapy: Innovations and Challenges - GLOBAL INFECTIONS 2026 (Netherlands)
- Research on Medicine and Vaccine for Covid-19 - INFECTIOUS DISEASES-2026 (France)
- Respiratory Diseases - Infectious Diseases_2026 (France)
- Respiratory Infections Beyond TB - Tuberculosis 2026 (France)
- Respiratory Infectious Diseases and Therapy - Infection Prevention 2026 (Spain)
- Respiratory Microbiome and Host Interactions - Tuberculosis 2026 (France)
- Respiratory Tract Infections: Viral and Bacterial Perspectives - Euro Infectious Diseases 2026 (UK)
- Risk Factors & Prevention - Infection Control 2026 (UK)
- Risk Factors & Prevention - Infection Control 2026 (UK)
- Sepsis and Critical Infections in Clinical Practice - Euro Infectious Diseases 2026 (UK)
- Sexual Health - STD-HIV AIDS-2026 (Spain)
- Sexually Transmitted Diseases - Infection Prevention 2026 (Spain)
- Sexually Transmitted Diseases - STD-HIV AIDS-2026 (Spain)
- Sexually Transmitted Diseases/ Sexually Transmitted Infections - Infectious Diseases_2026 (France)
- Surgical Site Infections - Infection Prevention 2026 (Spain)
- Surgical Site Infections - Infectious Diseases_2026 (France)
- Telemedicine and Digital Health in Respiratory Care - Tuberculosis 2026 (France)
- Telemedicine in Nephrology and Infectious Diseases: - GLOBAL INFECTIONS 2026 (Netherlands)
- Testing and Health Monitoring - STD-HIV AIDS-2026 (Spain)
- Transmission and Prevention - STD-HIV AIDS-2026 (Spain)
- Treatment for Tuberculosis - Infection Control 2026 (UK)
- Tropical diseases - Infection Prevention 2026 (Spain)
- Tropical Infectious Diseases - INFECTIOUS DISEASES-2026 (France)
- Tuberculosis - Infectious Diseases_2026 (France)
- Tuberculosis and Mycobacterial Diseases - Euro Infectious Diseases 2026 (UK)
- Vaccination for Infectious Diseases - GLOBAL INFECTIONS 2026 (Netherlands)
- Vaccine Development - Infection Congress 2026 (UK)
- Vaccine Development for Tuberculosis and Respiratory Infections - Tuberculosis 2026 (France)
- Vaccine Research & Development - Infection Control 2026 (UK)
- Vaccine Research and Development - Euro Infectious Diseases 2026 (UK)
- Vaccines and People with HIV - STD-HIV AIDS-2026 (Spain)
- Vaccines and Vaccination - INFECTIOUS DISEASES-2026 (France)
- Vaccines and Vaccination - Infectious Diseases_2026 (France)
- Vaccines and Vaccination for Rare Diseases: - Rare Diseases Congress 2026 (Czech Republic)
- Vector-Borne Diseases - Infection Congress 2026 (UK)
- Veterinary Diseases - INFECTIOUS DISEASES-2026 (France)
- Veterinary Diseases - Infection Prevention 2026 (Spain)
- Veterinary Infection Control - Infection Control 2026 (UK)
- Veterinary Infectious Disease - GLOBAL INFECTIONS 2026 (Netherlands)
- Viral & Bacterial Infectious Disease - GLOBAL INFECTIONS 2026 (Netherlands)
- Viral Infections and Outbreaks - Infection Congress 2026 (UK)
- Viral Infections and Recent Advancements - Infection Prevention 2026 (Spain)
- Viral Infections: Trends, Variants, and Global Impact - Euro Infectious Diseases 2026 (UK)
- Viral Infectious Diseases - INFECTIOUS DISEASES-2026 (France)
- Viral Infectious Diseases - Infectious Diseases_2026 (France)
- Zoonotic and Vector-Borne Diseases - Euro Infectious Diseases 2026 (UK)
- Zoonotic Diseases - Infection Congress 2026 (UK)